{"article_id": "WAT_q2_2020.txt", "article": ["to briefly review our operating results for the quarter , q2 sales declined 12 % , and adjusted earnings per share declined 2 % .", "exiting the second quarter , we are on track to achieve our $ 100 million cost savings plan for the year relative to our prior internal forecast .", "in the second quarter , we recorded net sales of $ 520 million , a decrease of approximately 12 % in constant currency .", "currency translation decreased sales growth by approximately 1 % resulting in a sales decline of 13 % as reported .", "in the quarter , sales into our pharmaceutical market declined 10 % , sales into our industrial market declined 13 % while academic and governmental markets declined 21 % .", "looking at our product line growth , our recurring revenue , which represents the combination of precision chemistry products and service revenue declined 3 % in the quarter while instrument sales declined 23 % .", "chemistry revenues were down 4 % in the quarter , driven mostly by weakness in academic and governmental .", "on the service side of our business , revenues were down 2 % as mid single digit growth in service contract revenues were offset by a decline in on - demand service revenues and spare parts .", "breaking second quarter product sales down further , sales related to waters branded products and services declined 12 % , while sales of ta - branded products and services declined 20 % .", "combined , lc and lcms instrument platform sales declined 24 % and ta 's instrumentation system sales declined 20 % .", "looking at our growth rates in the second quarter geographically , and on a constant currency basis , sales in asia declined 12 % with china down 20 % .", "sales in americas declined 15 % , including a 14 % decline in the us and european sales were down 9 % .", "we are on track to achieve cost savings of approximately $ 100 million for the year relative to our prior pre-covid internal plan .", "we achieved about 60 % of our planned annual savings in the first half of the year , which was better than expected , as we focused on aligning our operations and investments with our growth challenge in the second quarter .", "we anticipate the remaining 40 % of our cost savings to be achieved in the second half of the year .", "returning to our second quarter 's non-gaap financial performance , gross margin for the quarter was 59 % compared to 58.4 % in the second quarter of 2019 , primarily as a result of our cost savings actions .", "moving down the second quarter p&l , operating expenses decreased by approximately 13 % on a constant currency basis , and foreign currency translation decreased operating expense growth by approximately 1 % on a reported basis .", "in the quarter , our effective operating tax rate was 15.4 % compared to 15.7 % in the prior year .", "net interest expense was $ 9 million , an increase of about $ 3 million as anticipated .", "our average share count came in at 62.2 million shares , a share count reduction of approximately 11 % or about 7 million shares lower than in the second quarter of last year as a result of shares repurchased through the end of the first quarter of 2020 , subsequent to which we paused the share repurchase program .", "our non-gaap earnings per fully diluted share for the second quarter decreased to $ 2.10 in comparison to $ 2.14 last year .", "on a gaap basis , our earnings per fully diluted share decreased to $ 1.98 compared to $ 2.08 last year .", "in the second quarter of 2020 , our free cash flow came in at $ 175 million after funding $ 46 million of capital expenditures .", "excluded from free cash flow was $ 23 million related to the investment in our taunton precision chemistry operation .", "in the second quarter , this resulted in $ 0.34 of each dollar of sales converted into free cash flow , and $ 0.30 year to date .", "turning to working capital , accounts receivable days sales outstanding came in at 87 days this quarter , up 8 days compared to the second quarter of last year and inventories decreased by $ 8 million in comparison to the prior year quarter , reflecting revised production schedules .", "we ended the quarter with cash and short - term investments of $ 356 million and debt of $ 1.7 billion on our balance sheet at the end of the quarter .", "this resulted in a net debt position of $ 1.3 billion , and a net debt to ebitda ratio of about 1.8 times at the end of the second quarter .", "we also have $ 1 billion available on our bank revolver for a total available liquidity of $ 1.4 billion at the end of the second quarter .", "in terms of returning capital to shareholders , while our future capital structure target of approximately 2.5 times net debt to ebitda remains unchanged , our near - term focus is maintaining financial flexibility and preserving liquidity .", "due to the timing of our cost actions , as discussed earlier , we expect full - year operating expense growth in the range of negative 1 % to positive 1 % year - over - year in constant currency .", "for the full year at current rates , currency translation is expected to decrease sales growth by about one percentage point and to negatively impact earnings per share by about 3 percentage points .", "for the full year , net interest expense is expected to be in the range of $ 40 million to $ 42 million primarily due to lower interest rates ."], "summary_gold": "compname reports q2 earnings per share of $ 1.98 .<q>q2 non -gaap earnings per share $ 2.10 .<q>q2 gaap earnings per share $ 1.98 .<q>q2 sales $ 520 million versus refinitiv ibes estimate of $ 496.9 million .", "summary_pred": "our non-gaap earnings per fully diluted share for the second quarter decreased to $ 2.10 in comparison to $ 2.14 last year .<q>for the full year , net interest expense is expected to be in the range of $ 40 million to $ 42 million primarily due to lower interest rates .<q>in terms of returning capital to shareholders , while our future capital structure target of approximately 2.5 times net debt to ebitda remains unchanged , our near - term focus is maintaining financial flexibility and preserving liquidity .<q>looking at our product line growth , our recurring revenue , which represents the combination of precision chemistry products and service revenue declined 3 % in the quarter while instrument sales declined 23 % .<q>sales in americas declined 15 % , including a 14 % decline in the us and european sales were down 9 % .<q>on the service side of our business , revenues were down 2 % as mid single digit growth in service contract revenues were offset by a decline in on - demand service revenues and spare parts .<q>we anticipate the remaining 40 % of our cost savings to be achieved in the second half of the year .<q>we are on track to achieve cost savings of approximately $ 100 million for the year relative to our prior pre-covid internal plan .<q>currency translation decreased sales growth by approximately 1 % resulting in a sales decline of 13 % as reported .<q>we ended the quarter with cash and short - term investments of $ 356 million and debt of $ 1.7 billion on our balance sheet at the end of the quarter .<q>to briefly review our operating results for the quarter , q2 sales declined 12 % , and adjusted earnings per share declined 2 % .<q>combined , lc and lcms instrument platform sales declined 24 % and ta 's instrumentation system sales declined 20 % .<q>excluded from free cash flow was $ 23 million related to the investment in our taunton precision chemistry operation .", "len_article": 33, "len_summary_gold": 4, "len_summary_pred": 13, "len_sent_scores": 33}